Celltrion Files Brief and Motion to Compel in Infliximab Litigation

Goodwin
Contact
LinkedIn
Facebook
X
Send
Embed

As we previously reported, Celltrion has moved to dismiss Janssen v. Celltrion for lack of standing.  On Monday, Celltrion filed its reply brief in further support of that motion.  The same day, Celltrion filed a motion to compel production of documents relevant to its motion to dismiss.  Specifically, Celltrion seeks documents and communications relating to the assignment agreements at issue.

Stay tuned to Big Molecule Watch for further updates on this litigation.

 

 
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Goodwin | Attorney Advertising

Written by:

Goodwin
Goodwin
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Goodwin on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide